Neos Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2008-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.neostx.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
Phase 3
Completed
- Conditions
- Attention Deficit Hyperactivity Disorder (ADHD)
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-04-19
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- Neos Therapeutics, Inc
- Target Recruit Count
- 87
- Registration Number
- NCT01835548
- Locations
- 🇺🇸
Florida Clinical Research Center, Maitland, Florida, United States
🇺🇸Center for Psychiatry and Behavioral Medicine, Las Vegas, Nevada, United States
🇺🇸Duke University, Durham, North Carolina, United States
News
No news found